Biotechnology Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Biotechnology
Poxel SA (STU:7PO) Full Year 2023 Earnings Call Highlights: Strategic Moves and Financial Challenges
Poxel SA navigates financial restructuring and strategic partnerships amid increased net losses and reduced cash reserves. Oct 09, 2024
Biotechnology
Biovica International AB (OSTO:BIOVIC B) Q1 2025 Earnings Call Highlights: Strong US Sales Growth Amidst Flat Overall Revenue
Biovica International AB (OSTO:BIOVIC B) reports significant US sales growth and improved cash flow, but faces challenges in achieving broader revenue targets. Oct 09, 2024
Biotechnology
Champions Oncology Inc (CSBR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Improved Profitability Amidst Market Challenges
Champions Oncology Inc (CSBR) reports a 12% revenue increase and improved operational efficiencies, despite facing external market pressures and funding challenges. Oct 09, 2024
Biotechnology
Clinuvel Pharmaceuticals Ltd (CLVLF) (Q4 2024) Earnings Call Highlights: Record Revenue and Strategic Expansion
Clinuvel Pharmaceuticals Ltd (CLVLF) reports robust financial growth with a 15% revenue increase and outlines future expansion plans amidst rising expenses. Oct 09, 2024
Biotechnology
Circio Holding ASA (FRA:TA50) (H1 2024) Earnings Call Highlights: Strategic Financial Moves and Promising R&D Developments
Circio Holding ASA (FRA:TA50) strengthens its financial position with a significant loan waiver and rights issue, while advancing its innovative circVec technology. Oct 09, 2024
Biotechnology
Alk-Abello AS (AKBLF) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Upgraded Outlook
Alk-Abello AS (AKBLF) reports impressive Q2 performance with 21% organic revenue growth and raises full-year guidance amid robust European sales. Oct 09, 2024
Biotechnology
ArcticZymes Technologies ASA (FRA:B4V) Q2 2024 Earnings Call Highlights: Record Orders and Strategic Growth Initiatives
Despite a slight dip in sales, ArcticZymes Technologies ASA (FRA:B4V) focuses on long-term growth with new product launches and strategic partnerships. Oct 09, 2024
Biotechnology
Ultimovacs ASA (FRA:7UM) Q2 2024 Earnings Call Highlights: Navigating Financial Challenges and Strategic Innovations
Ultimovacs ASA outlines its cash preservation strategy and ongoing research advancements amid financial hurdles in its Q2 2024 earnings call. Oct 09, 2024
Biotechnology
WuXi Biologics (Cayman) Inc (WXXWY) Half Year 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges
Despite a flat overall revenue, WuXi Biologics (Cayman) Inc (WXXWY) shows resilience with strong non-COVID growth and strategic project acquisitions. Oct 09, 2024
Biotechnology
BiomX Inc (PHGE) Q2 2024 Earnings Call Highlights: Strong Financial Turnaround and Promising Clinical Developments
BiomX Inc (PHGE) reports a significant net income improvement and advances in clinical trials, despite rising R&D expenses and operational challenges. Oct 09, 2024
Biotechnology
Ascelia Pharma AB (FRA:7ZA) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
Ascelia Pharma AB (FRA:7ZA) reports significant progress in clinical trials and financing efforts, despite facing operational losses and market pressures. Oct 09, 2024
Biotechnology
Traws Pharma Inc (TRAW) Q2 2024 Earnings Call Highlights: Navigating Financial Challenges Amid Promising Clinical Advances
Traws Pharma Inc (TRAW) reports significant net loss but showcases promising developments in its clinical pipeline and strategic investor expansion. Oct 09, 2024
Biotechnology
Bio-Path Holdings Inc (BPTH) Q2 2024 Earnings Call Highlights: Financial Improvements and Promising Clinical Developments
Bio-Path Holdings Inc (BPTH) reports reduced net loss and advances in clinical trials, strengthening its position in the fight against AML. Oct 09, 2024
Biotechnology
Celcuity Inc (CELC) Q2 2024 Earnings Call Highlights: Strategic Advancements Amid Rising Expenses
Celcuity Inc (CELC) reports increased net loss and R&D expenses while making significant progress in clinical trials and strengthening its financial position. Oct 09, 2024
Biotechnology
Verrica Pharmaceuticals Inc (VRCA) Q2 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses and Competitive Challenges
Verrica Pharmaceuticals Inc (VRCA) reports strong YCANTH revenue and strategic advancements, but faces increased losses and market competition. Oct 09, 2024
Biotechnology
Vistagen Therapeutics Inc (VTGN) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges
Vistagen Therapeutics Inc (VTGN) reports increased R&D expenses amid promising clinical advancements and strong financial positioning. Oct 09, 2024
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers